1. Benefit-risk assessment for new drug and biological products: guidance for industry Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, October 2023 Subject(s): Biological ProductsDrug ApprovalDrug IndustryDrugs, InvestigationalGovernment RegulationPharmaceutical PreparationsRisk AssessmentUnited States
